Current Ratio of BioNexus Gene Lab Corp from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
BioNexus Gene Lab Corp quarterly Current Ratio in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • BioNexus Gene Lab Corp Current Ratio for the quarter ending 30 Sep 2025 was 437%, a 13% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

BioNexus Gene Lab Corp Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 437% -64% -13% 30 Sep 2025
Q2 2025 410% -92% -18% 30 Jun 2025
Q1 2025 456% +27% +6.4% 31 Mar 2025
Q4 2024 466% +64% +16% 31 Dec 2024
Q3 2024 500% +148% +42% 30 Sep 2024
Q2 2024 502% +175% +54% 30 Jun 2024
Q1 2024 429% +75% +21% 31 Mar 2024
Q4 2023 402% +54% +15% 31 Dec 2023
Q3 2023 352% +3.8% +1.1% 30 Sep 2023
Q2 2023 326% +8.8% +2.8% 30 Jun 2023
Q1 2023 354% +58% +20% 31 Mar 2023
Q4 2022 349% +73% +27% 31 Dec 2022
Q3 2022 349% +91% +35% 30 Sep 2022
Q2 2022 317% +58% +23% 30 Jun 2022
Q1 2022 296% +33% +13% 31 Mar 2022
Q4 2021 275% -18% -6% 31 Dec 2021
Q3 2021 258% -1471% -85% 30 Sep 2021
Q2 2021 259% -1753% -87% 30 Jun 2021
Q1 2021 262% -1777% -87% 31 Mar 2021
Q4 2020 293% -1773% -86% 31 Dec 2020
Q3 2020 1729% -420% -20% 30 Sep 2020
Q2 2020 2012% 30 Jun 2020
Q1 2020 2039% 31 Mar 2020
Q4 2019 2066% 31 Dec 2019
Q3 2019 2149% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.